Understanding the Uncommon Thoracic Tumors

Jemal A. , Siegel R. , Ward E. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106–130.

Chen L.C. , Travis W.D. , Krug L.M. Pulmonary neuroendocrine tumors: what (little) do we know? J Natl Compr Canc Netw. 2006; 4: 623–630.

Engels E.A. , Pfeiffer R.M. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003; 105: 546–551.

Silverman N.A. , Sabiston D.C. Jr . Mediastinal masses. Surg Clin North Am. 1980; 60: 757–777.

Gross J.L. , Younes R.N. , Haddad F.J. Soft-tissue sarcomas of the chest wall: prognostic factors. Chest. 2005; 127: 902–908.

Ho J.C. , Wong M.P. , Lam W.K. Lymphoepithelioma-like carcinoma of the lung. Respirology. 2006; 11: 539–545.

Loehrer PJ Sr , Chen M. , Kim K. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997; 15: 3093–3099.

Loehrer PJ Sr , Wang W. , Johnson D.H. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial. J Clin Oncol. 2004; 22: 293–299. Erratum in: J Clin Oncol. 2004; 22: 2261.